Transport & Travel Research (United Kingdom)

Purpose This study analyzes how trust in generative artificial intelligence (GenAI) competency and supplier–supplier connection affect innovation capacities and service innovation performance via the compatibility of GenAI and customer agility. Design/methodology/approach An innovative performance model was developed by integrating orientation, cooperation and orchestration (OCO) theory, the knowledge-based view and diffusion of innovation (DOI). Empirical data were gathered from travel agencies in Taiwan, and the model was evaluated using the partial least squares (PLS) approach. Findings This study demonstrates that trust in GenAI competency impacts the compatibility of GenAI and customer agility; the role of digital marketing innovation moderates the effect of customer agility on online consumption value and service innovation performance. Originality/value The study’s findings underline the antecedents and consequences of service innovation and provide further specific suggestions for travel agencies, focusing on applying GenAI to innovation in travel agencies.

Charging point infrastructure is a vital component of running electric vehicles (EV). Commercial EV users have particular demands that contrast markedly with private drivers requirements, who have been the main target of public charge point infrastructure development to date. The paper outlines results of research with both small/medium businesses with in-house operations (requiring some vehicles) and commercial operators with significant own-account or hire- and-reward fleets. It includes a summary of technical requirements of EV for commercial use, and draws conclusions on what is the optimal charging point infrastructure technology match. It makes a series of recommendations on how best to support EV to: - serve different types of commercial organisation; - meet current and future conventions on modes and type (connector), most relevant to commercial electric vehicles; - where and how to ensure access to charging point infrastructure if facilitated (at different scales and locations, including shared access); - other support for the EV business case (through fiscal/policy on parking, road charging and low emission zones).

Escherichia coli O26 and O157 have similar overall prevalences in cattle in Scotland, but in humans, Shiga toxin-producing E. coli O26 infections are fewer and clinically less severe than E. coli O157 infections. To investigate this discrepancy, we genotyped E. coli O26 isolates from cattle and humans in Scotland and continental Europe. The genetic background of some strains from Scotland was closely related to that of strains causing severe infections in Europe. Nonmetric multidimensional scaling found an association between hemolytic uremic syndrome (HUS) and multilocus sequence type 21 strains and confirmed the role of stx(2) in severe human disease. Although the prevalences of E. coli O26 and O157 on cattle farms in Scotland are equivalent, prevalence of more virulent strains is low, reducing human infection risk. However, new data on E. coli O26-associated HUS in humans highlight the need for surveillance of non-O157 enterohemorrhagic E. coli and for understanding stx(2) phage acquisition.

Abstract Re-enactment events have began to play a significant role in the calendars of individual attractions, regions or even nations to generate media exposure, develop inbound tourism activity and raise the cultural heritage profile of a locality for community development and/or regeneration purposes. The (re-)presentation of cultural heritage in these forms creates a unique set of interactions between landscapes, local communities, tourists and heritage organisations. In the recent past however, re-enactment events have been subjected to increased debate and criticism as to their educational value and meaning and for their contribution to understandings of cultural heritage in post-modern consumer societies. This paper presents an interdisciplinary review of these debates and draws on small scale research findings to reassess the value of re-enactment events as a means of presenting heritage to audiences. The paper argues that re-enacted historical events achieve a range of purposes and provides examples of evidence from a range of differing perspectives including: public policy and event organisers; re-enactors and academics in the field. It argues that the professional heritage industry, tourists, and re-enactors all contribute to making such events meaningful and as such they represent unique frames through which to understand issues of authenticity and identity in the production and consumption of post-modern cultural heritage attractions. Keywords: cultural heritagefestivalstourism and re-enactment eventsauthenticityidentity

Abstract This paper describes the various steps involved to safely suspend a HPHT well and to repair a number of leaks in the production tubing. The tubing leaks were the result of corrosion and occurred over a two hundred meter interval. Thorough analysis and associated difficulties to resolve this problem lead to the approach of cementing the tubing in place. Thus allowing the operator to test this gas well and increase the knowledge of the reservoir to develop this field. The process and solution will be described in great detail and will serve as the basis for similar problems in the future.

Cystic fibrosis patients have chronic bacterial infections of the respiratory tract, most commonly Pseudomonas aeruginosa. Although controversial, administration of antibiotic therapy during acute pulmonary exacerbations is standard practice. Fluoroquinolones are currently not indicated for use in young children because of the observation of arthropathy and damage to growing cartilage in beagle puppies. Because of its activity against P. aeruginosa and excellent oral bioavailability, ciprofloxacin offers a unique therapeutic alternative for this patient population. This prospective, randomized, double blind study compared the efficacy and safety of sequential intravenous/oral ciprofloxacin vs. ceftazidime/tobramycin in hospitalized pediatric cystic fibrosis patients with an acute pulmonary exacerbation associated with P. aeruginosa infection. One hundred thirty patients (ages 5 to 17 years) were randomized to receive either i.v. ciprofloxacin 10 mg/kg every 8 h for 7 days followed by oral ciprofloxacin 20 mg/kg every 12 h for a minimum of 3 days or i.v. ceftazidime 50 mg/kg every 8 h plus i.v. tobramycin 3 mg/kg every 8 h for a minimum of 10 days. Clinical, bacteriologic and safety responses were assessed throughout the study. All 84 patients (median age, 11 years; range, 5 to 17 years) valid for efficacy in both treatment groups demonstrated clinical improvement. Five patients experienced clinical relapses (3 ciprofloxacin, 2 ceftazidime/tobramycin) by the 2- to 4-week follow-up. Intent-to-treat analysis demonstrated similar clinical findings between the two treatment groups at both the end of therapy and follow-up. Clinical improvement correlated with improvement in pulmonary function studies and the acute clinical scoring system but not with bacteriologic eradication of Pseudomonas. DNA profiles demonstrated that irrespective of colony morphology, usually one clonal strain was associated with each patient's pulmonary exacerbation. Treatment-associated musculoskeletal events occurred with equal frequency (22% vs. 21%) in both study drug groups (n = 129), and arthralgias were within the range of rates for cystic fibrosis arthropathy. None of these events required study drug discontinuation. Sequential i.v./oral ciprofloxacin monotherapy offers a safe and efficacious alternative to standard parenteral therapy for acute pulmonary exacerbations in pediatric cystic fibrosis patients.